Literature DB >> 8406436

Long range restriction map of the von Hippel-Lindau gene region on human chromosome 3p.

S C Szymanski1, H Hummerich, F Latif, M I Lerman, G Röhrborn, E Schröder.   

Abstract

Von Hippel-Lindau disease is a heritable tumour syndrome caused by the loss of the function of a tumour suppressor gene on the short arm of human chromosome 3. The interval RAF1-D3S18 (3p25-3p26) has been identified by genetic linkage studies to harbour the von Hippel-Lindau gene. We have constructed a long range restriction map of this region and have succeeded in demonstrating the physical linkage of loci D3S726 (DNA probe LIB31-38), D3S18 (c-LIB-1, L162E5), D3S601 (LIB19-63) and D3S587 (LIB12-48). Since multipoint analysis has located D3S601 proximal to D3S726, the physical map should be oriented with D3S726 towards the telomere. The order and distances of probes within the von Hippel-Lindau gene region is as follows: telomere--LIB31-38--(< 280 kb)--c-LIB-1--(overlapping)--L162E5--(900-1600 kb)--(LIB19-63, LIB12-48)--centromere. In tissues that included blood, semen and Epstein-Barr-virus-transformed lymphocytes, we detected a putative CpG island flanking D3S18.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8406436     DOI: 10.1007/bf00244473

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  24 in total

1.  A new polymorphic probe on chromosome 3p: lambda LIB19-63' (D3S601).

Authors:  J Delisio; F Latif; G M Glenn; M Yao; H Brauch; K Hampsch; M L Orcutt; B Zbar; M I Lerman
Journal:  Nucleic Acids Res       Date:  1991-02-25       Impact factor: 16.971

2.  High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines.

Authors:  F Antequera; J Boyes; A Bird
Journal:  Cell       Date:  1990-08-10       Impact factor: 41.582

3.  Use of cyclosporin A in establishing Epstein-Barr virus-transformed human lymphoblastoid cell lines.

Authors:  M A Anderson; J F Gusella
Journal:  In Vitro       Date:  1984-11

4.  "A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1984-02       Impact factor: 3.365

5.  Von Hippel-Lindau (VHL) disease: distinct phenotypes suggest more than one mutant allele at the VHL locus.

Authors:  G M Glenn; L N Daniel; P Choyke; W M Linehan; E Oldfield; M B Gorin; S Hosoe; F Latif; G Weiss; M Walther
Journal:  Hum Genet       Date:  1991-06       Impact factor: 4.132

6.  Specific genetic change in tumors associated with von Hippel-Lindau disease.

Authors:  K Tory; H Brauch; M Linehan; D Barba; E Oldfield; M Filling-Katz; B Seizinger; Y Nakamura; R White; F F Marshall
Journal:  J Natl Cancer Inst       Date:  1989-07-19       Impact factor: 13.506

7.  Genetic flanking markers refine diagnostic criteria and provide insights into the genetics of Von Hippel Lindau disease.

Authors:  B R Seizinger; D I Smith; M R Filling-Katz; H Neumann; J S Green; P L Choyke; K M Anderson; R N Freiman; S M Klauck; J Whaley
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

8.  Mapping of von Hippel-Lindau disease to chromosome 3p confirmed by genetic linkage analysis.

Authors:  E R Maher; E Bentley; J R Yates; D Barton; A Jennings; I W Fellows; M A Ponder; B A Ponder; C Benjamin; R Harris
Journal:  J Neurol Sci       Date:  1990-12       Impact factor: 3.181

9.  Von Hippel-Lindau disease: a genetic study.

Authors:  E R Maher; L Iselius; J R Yates; M Littler; C Benjamin; R Harris; J Sampson; A Williams; M A Ferguson-Smith; N Morton
Journal:  J Med Genet       Date:  1991-07       Impact factor: 6.318

10.  Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma.

Authors:  B R Seizinger; G A Rouleau; L J Ozelius; A H Lane; G E Farmer; J M Lamiell; J Haines; J W Yuen; D Collins; D Majoor-Krakauer
Journal:  Nature       Date:  1988-03-17       Impact factor: 49.962

View more
  1 in total

1.  Localization of the Fanconi anemia complementation group D gene to a 200-kb region on chromosome 3p25.3.

Authors:  J A Hejna; C D Timmers; C Reifsteck; D A Bruun; L W Lucas; P M Jakobs; S Toth-Fejel; N Unsworth; S L Clemens; D K Garcia; S L Naylor; M J Thayer; S B Olson; M Grompe; R E Moses
Journal:  Am J Hum Genet       Date:  2000-04-12       Impact factor: 11.025

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.